Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in patients receiving ¹⁷⁷Lu-edotreotideData build upon previously reported COMPETE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results